President and CDO · Acumen Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$3,379
Shares
1,700
Price
$1.99
Executed
Jan 7, 2026
Disclosed
Jan 9, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 7 executedJan 9, 2026 disclosed
ABOS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Doherty James J. filed this Form 4 reporting a open-market sale of ABOS on Jan 7, 2026. It became public on Jan 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President and CDO
Doherty James J.cik:0002009718
Issuer
Acumen Pharmaceuticals, Inc.cik:0001576885
Revision history · 0
No field has changed since this record was first ingested.
ABOSAcumen Pharmaceuticals, Inc.